Propranolol-resistant infantile haemangiomas
- PMID: 23659587
- DOI: 10.1111/bjd.12417
Propranolol-resistant infantile haemangiomas
Abstract
Background: Propranolol is now widely used to treat severe infantile haemangiomas (IHs). Very few cases of propranolol-resistant IH (PRIH) are mentioned in the literature.
Objectives: To describe the characteristics of PRIHs.
Methods: A national, multicentre, retrospective, observational study was conducted from February 2011 to December 2011. All patients with PRIH evaluated by the members of the Groupe de Recherche Clinique en Dermatologie Pédiatrique from 1 January 2007 to 1 December 2011 were eligible.
Results: Among 1130 patients treated with propranolol for infantile haemangioma, 10 (0.9%) had PRIHs. Haemangioma propranolol resistance was observed at all ages during early childhood and at any proliferation stage.
Conclusions: PRIH is a rare phenomenon that raises questions and merits further investigation.
© 2013 British Association of Dermatologists.
Similar articles
-
Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.J Paediatr Child Health. 2012 Oct;48(10):902-6. doi: 10.1111/j.1440-1754.2012.02521.x. Epub 2012 Aug 16. J Paediatr Child Health. 2012. PMID: 22897120
-
Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.J Plast Reconstr Aesthet Surg. 2011 Apr;64(4):445-51. doi: 10.1016/j.bjps.2010.07.009. Epub 2010 Aug 24. J Plast Reconstr Aesthet Surg. 2011. PMID: 20797926 Clinical Trial.
-
[Propranolol therapy for periocular and orbital infantile haemangiomas].Klin Monbl Augenheilkd. 2014 Oct;231(10):971-9. doi: 10.1055/s-0034-1383088. Epub 2014 Oct 21. Klin Monbl Augenheilkd. 2014. PMID: 25333232 Review. German.
-
Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol.Br J Dermatol. 2013 Dec;169(6):1252-6. doi: 10.1111/bjd.12432. Br J Dermatol. 2013. PMID: 23662995
-
Use of propanolol for treatment of large infantile haemangiomas-a report of two cases and review of the literature.Ann Acad Med Singap. 2013 May;42(5):253-6. Ann Acad Med Singap. 2013. PMID: 23771115 Review. No abstract available.
Cited by
-
Our experience with propranolol for infantile hemangioma.Skin Res Technol. 2023 Apr;29(4):e13310. doi: 10.1111/srt.13310. Skin Res Technol. 2023. PMID: 37113082 Free PMC article.
-
IADVL SIG Pediatric Dermatology (Academy) Recommendations on Hemangioma of Infancy (HOI).Indian Dermatol Online J. 2023 Mar 3;14(2):172-186. doi: 10.4103/idoj.idoj_52_22. eCollection 2023 Mar-Apr. Indian Dermatol Online J. 2023. PMID: 37089858 Free PMC article. Review.
-
Management of infantile hemangiomas-experience of a tertiary hospital.Eur J Pediatr. 2023 Apr;182(4):1611-1618. doi: 10.1007/s00431-023-04827-2. Epub 2023 Jan 27. Eur J Pediatr. 2023. PMID: 36705724
-
KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells.Cancer Sci. 2023 Apr;114(4):1569-1581. doi: 10.1111/cas.15708. Epub 2023 Jan 10. Cancer Sci. 2023. PMID: 36572002 Free PMC article.
-
Concurrent subglottic and carotid sheath haemangiomas in a paediatric patient - an extremely rare clinical entity.J Surg Case Rep. 2022 Nov 22;2022(11):rjac542. doi: 10.1093/jscr/rjac542. eCollection 2022 Nov. J Surg Case Rep. 2022. PMID: 36425584 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
